请选择 进入手机版 | 继续访问电脑版

一健社区 | 专业的功能性胃肠病数据平台

 找回密码
 立即注册

QQ登录

只需一步,快速开始

扫一扫,访问微社区

12
返回列表 发新帖
楼主: 一健社区

[转]人体微生态尤其是肠道微生态为新药研发提供前所未有的机遇和挑战

[复制链接]

11

主题

34

帖子

4万

积分

管理员

Rank: 9Rank: 9Rank: 9

积分
40138
 楼主| 发表于 2017-8-17 15:12:25 | 显示全部楼层
4 结语

      显然,在新药研发领域,如果不能够及时把握未来的发展趋势,将会很容易出现发展缓慢甚至停滞不前的局面。目前国际药物研发团队已经在面向人体药物研发领域做出了突出贡献,在研发抗病毒抗细菌抗真菌感染、抗烈性传染病等领域的药物研发中也取得了辉煌的成就,然而,随着医学领域的快速发展,随着人们不断认识到人体的健康越来越离不开人体共生微生态系统的时候,如何在药物领域能够研发出高质量的既能够促进人体健康、同时又能够促进人体微生态健康、而且又能够使得人体和微生态两者之间相互作用达到最大的健康程度的药物,将是未来新药研发领域的重中之重。毕竟,不论是医学研究还是药物研发,我们一定要将疾病防控与治疗放在首位,突出预防为主、治疗为辅的医学核心思路,需要避免为研发新药而研发新药,从而有利于实现“不忘初心,方得健康”的医学目标。相信在基于人体与共生微生物构成双遗传系统的“人菌平衡”观点的前提下,新药研发将有望走出困境,走向新的发展阶段。
      综上所述,无论是传统医学和现代医学领域,还是药物研发领域,都曾经辉煌过,然而在慢病高发面前也都遇到了巨大的困难和挑战,同时又是新的机遇的开始,尤其是一个学科需要面临快速发展的前夜,需要将先前的发展模式以壮士断腕式进行升级发展,的确需要付出代价;然而,如果不这样做,仍然沿着传统路线进行药物研发,却又很难走出目前的道路。因此,即使再难,药物研发的思路、连同当前医学的理论体系,有可能都已经被日渐高发的慢病倒逼到了不得不改的地步。凡是过去,皆为序曲,与其修修补补,还不如从头创新,重新认识清楚“人菌平衡”尤其是健康的人体微生态系统对于人体健康的至关重要性,让颠覆式的创新思路引领我国和国际药物领域的研发走上一条光明大道,让能够惠及我国民众的健康梦早日到来。

参考文献:
[1] Zhang CG. New medicine and bacteriocentric theoryand a revolution in prevention and control of chronicdiseases[J]. Sci Tech Rev(科技导报),2015,33(22):106-111.[2] Zhu B,Wang X,Li L. Human gut microbiome:thesecond genome of human body[J]. Protein Cell,2010,1(8):718-725.[3] Zhang CG. Research of Artemisinin and its implica⁃tions of Youyou Tu winning a Nobel Prize[J]. SciTech Rev(科技导报),2015,33(20):86-89.[4] Bäckhed F,Ding H,Wang T,Hooper LV,Koh GY,Nagy A,et al. The gut microbiota as an environ⁃mental factor that regulates fat storage[J]. ProcNatl Acad Sci USA,2004,101(44):15718-15723.[5] Fei N,Zhao L. An opportunistic pathogen isolatedfrom the gut of an obese human causes obesity ingermfree mice[J]. ISME J,2013,7(4):880-884.[6] Huang QJ,Teng SZ,GAO DW,Dong HX,ShaJB,Gong WJ,et al. Emergency plans of flexibleabrosia to raise efficiency in disaster rescue[J].Disast Med Rescue:Electronic Edition(灾害医学与救援:电子版),2015,4(2):81-85.[7] Hsiao EY,Mcbride SW,Hsien S,Sharon G,Hyde ER,Mccue T,et al. Microbiota modulate be⁃havioral and physiological abnormalities associat⁃ed with neurodevelopmental disorders[J]. Cell,2013,155(7):1451-1463.[8] Luo J,Jin F. Recent advances in understandingthe impact of intestinal microbiota on host behavior[J]. Chin Sci Bull(科学通报),2014,59(22):2169-2190.[9] Zhang FM. Move standardization of fecal microbiotatransplantation into Mainstream[J]. Chin J DigEndosc(中华消化内镜杂志),2014,31(2):61-63.[10] Zheng M. Research progress of antitumor pharma⁃cology of traditional Chinese medicine polysaccha⁃ride[J]. Int J Tradit Chin Med(国际中医中药杂志),2000,22(05):259-263.[11] Xu J,Lian F,Zhao L,Zhao Y,Chen X,Zhang X,et al. Structural modulation of gut microbiota duringalleviation of type 2 diabetes with a Chinese herbalformula[J]. ISME J,2015,9(3):552-562.[12] Cui B,Feng Q,Wang H,Wang M,Peng Z,Li P,et al. Fecal microbiota transplantation throughmidgut for refractory Crohn′ s disease: safety,feasibility,and efficacy trial results[J]. J Gastroen⁃terol Hepatol,2015,30(1):51-58.[13] Chen B,Wang Y, Lei F, Yin YS, Wang X.Research progress of gut microbes in vitro model[J]. Chin J Microecol(中国微生态学杂志),2012,24(8):766-768.Human microecology, especially gut microflora providesunprecedented opportunities and challenges fornew drug research and developmentZHANG Cheng-gang(Beijing Institute of Radiation Medicine,State Key Laboratory of Proteomics,Research Centerfor Military Cognitive and Mental Health of PLA,Beijing 100850,China)Abstract:Since entering the 21st century,the trend of high incidence of chronic diseases in the in⁃ternational community has not been effectively controlled and the pharmaceutical and medical fields• 712 •中国药理学与毒理学杂志2016 年7 月第30 卷第7 期Chin J Pharmacol Toxicol,Vol 30,No 7,Jul 2016are put forward new challenges. Both the development and evaluation of chemical drugs,biologicaldrugs or traditional Chinese medicine are facing with how to significantly improve the efficacy andreduce the side effect of the drugs. With the coming of the accurate medical treatment as well as thebig data era,new opportunities and challenges are needed either in the development of new drugs ornew use of old drugs. However,as known that the human body consists of the symbiotic microbialgroups of human microecological system especially the gut microecology system is more and moreimportant in human health and disease,and even part diseases such as obesity and diabetes have acertain degree of causality with the gut microflora,so we need to reanalyze the core ideas about drugdevelopment or even the current medical theory system. Therefore,it is possible to step out of the oldway of current drug development in the new period,to make new contributions on the real effectiveimplementation of prevention and control of chronic diseases. According to international human bodymicroecological especially the research progress of gut microecological field,systematic analysis ofthe problems existing in the current research and development of new drugs,will not only focus on thehuman body itself,but also the human microecology as well as the balance between human and micro⁃ecological,which will promote rapid development of research and development of new drugs andprevention and control of chronic disease in order to improve the physical and mental health services inour country.Key words:human microecology;gut microflora;gut flora;new drug research and development;traditional Chinese medicine;gut flora-centric theory;balance between human and microfloraFoundation item:The project supported by National Natural Science Foundation of China(81371232);National Megaprojectof Science Research of China for New Drug Development(2012ZX09102301- 016);and National Key BasicResearch and Development Program(973 Program)(2012CB518200)Corresponding author:ZHANG Cheng-gang,E-mail:zcgweb@126.com
回复

使用道具 举报

15

主题

67

帖子

176

积分

注册会员

Rank: 2

积分
176
发表于 2017-8-17 15:31:31 | 显示全部楼层
好文章,值得分享
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

一曜集团|玉曜生物|百曜生物|迪星药辅|一健社区 | 专业的功能性胃肠病数据平台 ( 沪ICP备17040470号

GMT+8, 2019-3-19 08:32 , Processed in 0.122964 second(s), 5 queries , File On.

Powered by Discuz! X3.3

© 2018 上海一曜健康科技有限公司

快速回复 返回顶部 返回列表